Van Ommen; Garrit-Jan Boudewijn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Ommen; Garrit-Jan Boudewijn.The latest application filed is for "method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means".

Company Profile

9.26.42

Van Ommen; Garrit-Jan Boudewijn - Amsterdam NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA Grant 11,427,820 - De Kimpe , et al. August 30, 2	2022-08-30
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means App 20210207138 - Platenburg; Gerard Johannes ; et al.	2021-07-08
Means and methods for counteracting muscle disorders Grant RE48,468 - De Kimpe , et al. March 16, 2	2021-03-16
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites From Proteins App 20200332298 - van Roon-Mom; Wilhelmina M.C. ; et al.	2020-10-22
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20200239886 - De Kimpe; Josephus Johannes ; et al.	2020-07-30
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites, The Hchwa-d Mutation, And Trinucleotide Repeat Expansi App 20200224203 - van Roon-Mom; Wilhelmina M.C. ; et al.	2020-07-16
Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions Grant 10,590,421 - van Roon-Mom , et al.	2020-03-17
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means App 20190292541 - Platenburg; Gerard Johannes ; et al.	2019-09-26
Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins Grant 10,364,432 - van Roon-Mom , et al.	2019-07-30
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20190177725 - De Kimpe; Josephus Johannes ; et al.	2019-06-13
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20190119679 - De Kimpe; Josephus Johannes ; et al.	2019-04-25
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20190112604 - De Kimpe; Josephus Johannes ; et al.	2019-04-18
Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means Grant 10,246,707 - Platenburg , et al.	2019-04-02
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA Grant 9,926,557 - De Kimpe , et al. March 27, 2	2018-03-27
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure Grant 9,896,687 - van Ommen , et al. February 20, 2	2018-02-20
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites, The Hchwa-d Mutation, And Trinucleotide Repeat Expansions App 20170226521 - van Roon-Mom; Wilhelmina M.C. ; et al.	2017-08-10
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites From Proteins App 20170175117 - van Roon-Mom; Wilhelmina M.C. ; et al.	2017-06-22
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20170107512 - De KIMPE; Josephus Johannes ; et al.	2017-04-20
Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins Grant 9,611,471 - van Roon-Mom , et al. April 4, 2	2017-04-04
Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA Grant 9,528,109 - De Kimpe , et al. December 27, 2	2016-12-27
Means And Methods For Counteracting Muscle Disorders App 20160304864 - De KIMPE; Josephus Johannes ; et al.	2016-10-20
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20160251658 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2016-09-01
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20160194636 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2016-07-07
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20160168570 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2016-06-16
Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL Grant 9,353,169 - Lesnik Oberstein , et al. May 31, 2	2016-05-31
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means App 20160053262 - Platenburg; Gerard Johannes ; et al.	2016-02-25
Means and methods for counteracting muscle disorders Grant 9,243,245 - De Kimpe , et al. January 26, 2	2016-01-26
Means And Methods For Modulating Notch3 Protein Expression And/or The Coding Region Of Notch3; Compositions And Use Thereof In The Treatment Of Cadasil App 20150274796 - Lesnik Oberstein; Saskia Anne-Marie Jenny ; et al.	2015-10-01
Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means Grant 9,139,828 - Platenburg , et al. September 22, 2	2015-09-22
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20150218559 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2015-08-06
Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL Grant 9,062,311 - Lesnik Oberstein , et al. June 23, 2	2015-06-23
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20150073037 - De Kimpe; Josephus Johannes ; et al.	2015-03-12
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20140357698 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2014-12-04
Modulation Of Exon Recognition In Pre-mrna By Interfering With The Secondary Rna Structure App 20140357855 - Van DEUTEKOM; Judith Christina Theodora ; et al.	2014-12-04
Molecule for treating an inflammatory disorder Grant 8,802,645 - Van Ommen , et al. August 12, 2	2014-08-12
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20140221458 - De Kimpe; Josephus Johannes ; et al.	2014-08-07
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20140128592 - De Kimpe; Josephus Johannes ; et al.	2014-05-08
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20140113955 - De Kimpe; Josephus Johannes ; et al.	2014-04-24
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites, The Hchwa-d Mutation, And Trinucleotide Repeat Expansions App 20140039037 - VAN ROON-MOM; WIHELMINA M. C. ; et al.	2014-02-06
Antisense Oligonucleotide Directed Removal Of Proteolytic Cleavage Sites From Proteins App 20130198877 - van Roon-Mom; Wilhelmina M. C. ; et al.	2013-08-01
Means and method for inducing exon-skipping Grant 8,361,979 - Aartsma-Rus , et al. January 29, 2	2013-01-29
Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene Grant 8,304,398 - 't Hoen , et al. November 6, 2	2012-11-06
Molecule For Treating An Inflammatory Disorder App 20120259002 - Van Ommen; Garrit-Jan Boudewijn ; et al.	2012-10-11
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means App 20120059042 - Platenburg; Gerard Johannes ; et al.	2012-03-08
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA App 20120022134 - DE KIMPE; JOSEPHUS JOHANNES ; et al.	2012-01-26
Means And Methods For Modulating Notch3 Protein Expression And/or The Coding Region Of Notch3; Compositions And Use Thereof In The Treatment Of Cadasil App 20110318787 - Lesnik Oberstein; Saskia Anne-Marie Jenny ; et al.	2011-12-29
Means and methods for counteracting muscle disorders App 20110294753 - De Kimpe; Josephus Johannes ; et al.	2011-12-01
Methods And Means For Efficient Skipping Of At Least One Of The Following Exons Of The Human Duchenne Muscular Dystrophy Gene: 43, 46, 50-53 App 20110263682 - De Kimpe; Josephus Johannes ; et al.	2011-10-27
Therapeutic Intervention In A Genetic Disease In An Individual By Modifying Expression Of An Aberrantly Or Abnormally Expressed Gene App 20100125099 - 't Hoen; Peter Abraham Christiaan ; et al.	2010-05-20
Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure App 20090312532 - Van Deutekom; Judith Christina Theodora ; et al.	2009-12-17
Means And Method For Inducing Exon-skipping App 20090269755 - Aartsma-Rus; Annemieke ; et al.	2009-10-29
Induction of exon skipping in eukaryotic cells App 20090228998 - van Ommen; Garrit-Jan Boudewijn ; et al.	2009-09-10
Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination Grant 7,507,800 - van Ommen , et al. March 24, 2	2009-03-24
Induction of exon skipping in eukaryotic cells App 20080209581 - van Ommen; Garrit-Jan Boudewijn ; et al.	2008-08-28
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure App 20060147952 - van Ommen; Garrit-Jan Boudewijn ; et al.	2006-07-06
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure App 20060099616 - van Ommen; Garrit-Jan Boudewijn ; et al.	2006-05-11
Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination App 20050019782 - van Ommen, Garrit-Jan Boudewijn ; et al.	2005-01-27
Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination Grant 6,733,966 - van Ommen , et al. May 11, 2	2004-05-11
Induction of exon skipping in eukaryotic cells App 20030235845 - van Ommen, Garrit-Jan Boudewijn ; et al.	2003-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.